STN: BL 125413/0
Proper Name: HPC, Cord Blood
Trade Name: ALLOCORD
Manufacturer: SSM Cardinal Glennon Children's Medical Center
- For use in unrelated donor hematopoietic progenitor cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment.
May 30, 2013 Approval Letter - ALLOCORD
To introduce or deliver for introduction into interstate commerce HPC, Cord Blood manufactured from the date of this authorization forward.
Summary Basis for Regulatory Action, May 30, 2013 - ALLOCORD May 30, 2013 Summary Basis for Regulatory Action for ALLOCORD Approval History, Letters, Reviews, and Related Documents - ALLOCORD[ARCHIVED]
FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.